ImmuCell Corporation (ICCC) — Cash Flow Quality Index

Latest as of June 2026: 1.65x

ImmuCell Corporation (ICCC) has a Cash Flow Quality Index of 1.65x as of June 2026. Operating cash flow of $3.02 Million exceeds net income of $1.83 Million, indicating high earnings quality where cash backs reported profits. Explore ICCC operating cash flow to total debt to assess how comfortably operating cash covers total debt obligations.

Cash Flow Quality Index

1.65x
Operating CF / Net Income

Operating Cash Flow

$3.02 Million
USD

Net Income

$1.83 Million
USD

Data as of

Jun 2026
Most recent filing

ImmuCell Corporation Cash Flow Quality Index (1997–2016)

Historical Cash Flow Quality Index for ImmuCell Corporation across 14 annual periods. Values consistently above 1.0x indicate high-quality earnings. For the full cash flow conversion analysis, see ImmuCell Corporation cash conversion from operations.

Annual Cash Flow Quality Index for ImmuCell Corporation (1997–2016)

Year-by-year earnings quality comparison for ImmuCell Corporation.

Year Quality Index Operating CF (USD) Net Income YoY Change
2016 -0.64x $-323.90K $508.45K ▼ -126.6%
2015 2.39x $2.90 Million $1.21 Million ▼ -74.5%
2013 9.36x $1.10 Million $117.39K ▲ +143.2%
2012 3.85x $344.39K $89.51K ▲ +628.8%
2007 0.53x $349.56K $662.14K ▼ -94.4%
2006 9.46x $1.36 Million $143.52K ▲ +775.7%
2005 1.08x $764.78K $707.78K ▼ -88.6%
2004 9.46x $1.36 Million $143.52K ▲ +177.2%
2003 3.41x $1.40 Million $411.22K ▲ +59.4%
2002 2.14x $1.90 Million $886.24K ▼ -0.7%
2001 2.16x $906.00K $420.00K ▲ +5781.0%
2000 0.04x $81.50K $2.22 Million ▼ -97.0%
1999 1.23x $679.70K $550.84K ▲ +270.2%
1997 0.33x $100.00K $300.00K
Cash Flow Quality Index = Operating Cash Flow / Net Income. Ratios above 1.0x indicate cash-backed earnings.